For Covid-19 related information, please refer to the Ministry of Health and Family Welfare Website
Dr. Mashood Siddiqi


Consultant Physician With Special Interest In Metabolic Bone Disease
Liverpool University Hospital Foundation Trust, Liverpool, UK
Hon. Clinical Lecturer
University Of Liverpool, UK

EDUCATIONAL BACKGROUND

MBBS: Prince of Wales Medical College, Patna, India
M.D. Gen.Med: Patna University, Patna, India
Dip.Ger.Med.(RCP Lond.) 1989
MRCP Ireland 1989
FRCP Ireland 2002
GMC REGISTRATION (Specialist Registration): General (internal) medicine from 19 Sep 1996, Geriatrics from 19 Sep 1996, Trainer recognised by the GMC

RESEARCH

TOPAZ trial - Multi centre trial - on going – Long term trial for treatment of Osteogenesis Imperfecta with Teriparatide.
Phase IV trials of Alendronate & Risedronate with Edgebright Ltd. & Synexus 1995-1999
PRISM – Multi centre trial - Long term trial for treatment of Paget’s disease of bone. Presented at ASBMR – Philadelphia Sept’06
ZiPP – 2010-11 sponsors Edinburgh university
OSSO – Multi centre 3 year observational study in severely osteoporotic pa-tients - Presented at ASBMR – Philadelphia Sept ‘06
Strontium Ranelate – Long term follow up study – Sponsor Servier labs
PACE study - PTH – 1-84 –in Severely osteoporotic patients – Sponsors - Ny-comed - Takeda
Phase IV trial Odanacatib – 2011-2012 including bone biopsies – Sponsors -MSD

AFFILIATIONSMEMBERSHIP

British Geriatric Society
Royal Osteoporosis Society – Also reviewer of Bone Services
Fellow of Royal College of Physicians, Ireland
Fellow of Indian Geriatric Society
British Medical Association
British Iinternational Doctors Association
American Society of Bone Mineral Research (ASBMR)

LECTURES AND TALKS

Regular talks on osteoporosis in local and regional meetings 1998-2020
Osteoporosis update – National meeting London 2017
Recent Advances in Osteoporosis Prestbury 2002
Management of Osteoporosis Chorley 1999
Osteo-College - Series of talks on Osteoporosis to medical practitioners around the UK 2000-2003
Annual Meeting of National Osteoporosis Society 1998,1999,2000,2001
Regional Osteoporosis Meetings Cumbria 1998

PAPERS AND CLINICAL PRESENTATIONS

VITAMIN D DEFICIENCY, COVID-19 AND BAME COMMUNITY.
“Vit D deficiency, COVID-19 and the BAME community” BIDA J;Issue 3:Vol 26:6-8, 2020
Osteoporosis Int. 2018 Suppl 1 Vol 29;2018 Ossification of Posterior Longi-tudinal Ligament (OPLL) associated with Osteopathia Striata with Cranial Sclerosis (OSCS). Presented at WCO-IOF-ESCEO Krakow Poland April 2018
Osteoporosis Int.2016 Suppl 1 April 2016 - 10 years experience of using Teri-paratide in Severe osteoporosis. Presented at WCO-IOF-ESCEO Malaga, Spain April 2016
Treatment of Osteoporotic Vertebral Compression Fractures: Applicability of Appropriateness Criteria in Clinical Practice. Pain Physician 2016; 19:E113-E120 • ISSN 2150-1149
Osteoporosis Int.2015 Suppl1 March 2015-Vertebral Fracture Clinic; one year experience. presented at WCO-IOF-ESCEO Milan Italy
Criteria for the Appropriate Treatment of Osteoporotic Vertebral Compression Fractures. Pain Physician 2013; 16:E519-E530
Osteoporosis Int. 2013 Suppl 3 Vol 8 Criteria for the appropriate treatment of osteoporotic vertebral compression fractures. Presented at ECCEO - Rome
Osteoporosis Int 2013 Suppl 3 Vol 8 Prescribing for osteoporosis associated with other musculoskeletal conditions. Presented at ECCEO - Rome
Archives of Osteoporosis 2012, Suppl 1 Vol 7 Denosumab in osteoporosis – indications for use, patient acceptability and side effects. Presented at IOF- Sao Paulo, Brazil
Osteoporosis Int 2012 Suppl 2 Vol 23 Improving compliance with Strontium Ranelate therapy by low initial dose. Presented at ECCEO Bordeux France
Osteoporosis Int 2011Suppl 5 Oct vol.22 Compliance with Osteoporosis treatment advised by fracture liaison service.Presented at IOF Dubai
Osteoporosis Int.2010 Suppl 3 Nov vol,21, Relation between P1NP and bone density changes in patients on Teriparatide treatment previously treated with Bisphosphonates. Presented at IOF Singapore
Osteoporosis Int 2010 Suppl 5 Dec, Vol 21, Zoledronic acid in osteoporosis- patient satisfaction, acceptability and side effects in patients with and with out previous bisphosphonates. Presented at ECCEO Florence
Age & Ageing 2010:39(Suppl 1) i14, Audit on compliance with treatment advised by Fracture Liaison Service
Osteoporosis Int 2009 Suppl 1 Vol 20 Intravenous Ibandronate patient satisfaction, acceptability and side effects in patients with or without previous IV bisphosphonates. Presented at IOF Athens
Age & ageing 2008;37:142-150. Can early onset bone loss be effectively man-aged in post stroke patients? An integrative review of the evidence. Bone 2008;43 S76-S93. Intravenous Ibandronate-Patient satisfaction, acceptability and side effects. Presented at IOF Beijing
Osteoporosis Int.2008 19 (Suppl 2): S251-S497. Intravenous Ibandronate- Patient satisfaction, acceptability and side effects in patients with or without previous IV Bisphosphonate. Presented at NOS Manchester
Falling & Fear of falling in newly diagnosed Osreoporosis patients C Weatherell, M A Siddiqi, World Congress on Osteoporosis, Toronto, June 2006, Osteoporosis Int. 2006:17(Suppl 2) S175 7th ECCEO, Porto Portugal 2007, Osteoporosis Int 2007:18(Suppl 1) S52
A New look at Fear of falling C Weatherell, M A Siddiqi, NOS meeting, Harrogate, June 2006
Are osteoporotic fractures being adequately investigated? G Chami, Mashood Siddiqi, BMC Family Practice 7 Feb 2006
PRISM – National study for the treatment of Paget’s Disease 5 year multi centre study – completed June 2006 On going Phase 2.
OSSO – Observational study of Severe Osteoporosis – 4 year multicentre study completed June 2005
Investigation of Fracture for underlying osteoporosis, a survey of Orthopaedic surgeons and General Practitioners. Lee Jays, MA Siddiqi BOA, Birmingham,August 2001
Giardiasis, an uncommon cause of osteoporosis in a young male J Bussin, MASiddiqi Osteoporosis International Sept.2001
Cyclical Etidronate and Calcium therapy in the elderly, NHL Harper,MA Siddiqi & P Ahmed Bone vol.17 p 612 Jan.1996
Cyclical Etidronate / Calcium therapy in Elderly ( poster presentation). NHL Harper,MA Siddiqi & P Ahmed Third Workshop on Bisphosphonates Davos, Switzerland Jan.11-13 1996
Success of Cyclical etidronate Calcium therapy in older osteoporotic subjects. NHL Harper,MA Siddiqi & P Ahmed British Geriatric Society - Spring meeting Torquey. 13-14 April 1995
Ambulatory Blood Pressure Monitoring in Elderly British Geriatric Society North West Warrington Aug.1992
Stroke Unit - A clinical audit British Geriatric Society North West Liverpool Aug.1991
Hydration status of elderly patients on admission and stay in Geriatric wards - a clinical audit. British Geriatric Society North West Warrington Jan.1991
Register Now